Literature DB >> 23715324

A panoramic view of acute myeloid leukemia.

Sai-Juan Chen1, Yang Shen, Zhu Chen.   

Abstract

A recent study in the New England Journal of Medicine reports the genomic and epigenomic changes in adult acute myeloid leukemia (AML). The patterns of somatic mutation suggest biologically relevant connections between the functional categories of genes driving AML.

Entities:  

Mesh：

Year:  2013        PMID： 23715324     DOI： 10.1038/ng.2651

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  15 in total

1.  Mutant DNMT3A: teaming up to transform.

Authors:  Christian Thiede
Journal:  Blood       Date:  2012-06-14       Impact factor: 22.113

2.  Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

Authors:  Felicitas Thol; Frederik Damm; Andrea Lüdeking; Claudia Winschel; Katharina Wagner; Michael Morgan; Haiyang Yun; Gudrun Göhring; Brigitte Schlegelberger; Dieter Hoelzer; Michael Lübbert; Lothar Kanz; Walter Fiedler; Hartmut Kirchner; Gerhard Heil; Jürgen Krauter; Arnold Ganser; Michael Heuser
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

3.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Mrinal Y Shah; Jonathan D Licht
Journal:  Nat Genet       Date:  2011-03-29       Impact factor: 38.330

4.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

Review 5.  Acute myeloid leukemia: the challenge of capturing disease variety.

Authors:  Bob Löwenberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

Review 6.  Gene mutations of acute myeloid leukemia in the genome era.

Authors:  Tomoki Naoe; Hitoshi Kiyoi
Journal:  Int J Hematol       Date:  2013-01-29       Impact factor: 2.490

7.  Recurring mutations found by sequencing an acute myeloid leukemia genome.

Authors:  Elaine R Mardis; Li Ding; David J Dooling; David E Larson; Michael D McLellan; Ken Chen; Daniel C Koboldt; Robert S Fulton; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Devin P Locke; Vincent J Magrini; Rachel M Abbott; Tammi L Vickery; Jerry S Reed; Jody S Robinson; Todd Wylie; Scott M Smith; Lynn Carmichael; James M Eldred; Christopher C Harris; Jason Walker; Joshua B Peck; Feiyu Du; Adam F Dukes; Gabriel E Sanderson; Anthony M Brummett; Eric Clark; Joshua F McMichael; Rick J Meyer; Jonathan K Schindler; Craig S Pohl; John W Wallis; Xiaoqi Shi; Ling Lin; Heather Schmidt; Yuzhu Tang; Carrie Haipek; Madeline E Wiechert; Jolynda V Ivy; Joelle Kalicki; Glendoria Elliott; Rhonda E Ries; Jacqueline E Payton; Peter Westervelt; Michael H Tomasson; Mark A Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Daniel C Link; Matthew J Walter; Timothy A Graubert; John F DiPersio; Richard K Wilson; Timothy J Ley
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

8.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

9.  CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.

Authors:  Ota Fuchs; Dana Provaznikova; Marcela Kocova; Arnost Kostecka; Pavla Cvekova; Radana Neuwirtova; Petr Kobylka; Jaroslav Cermak; Jana Brezinova; Jiri Schwarz; Jana Markova; Peter Salaj; Hana Klamova; Jacqueline Maaloufova; Petr Lemez; Ludmila Novakova; Katerina Benesova
Journal:  Blood Cells Mol Dis       Date:  2008-01-08       Impact factor: 3.039

10.  Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.

Authors:  Thomas Prébet; Nicolas Boissel; Sarah Reutenauer; Xavier Thomas; Jacques Delaunay; Jean-Yves Cahn; Arnaud Pigneux; Bruno Quesnel; Francis Witz; Sylvain Thépot; Valérie Ugo; Christine Terre; Christian Recher; Emmanuelle Tavernier; Mathilde Hunault; Benjamin Esterni; Sylvie Castaigne; François Guilhot; Hervé Dombret; Norbert Vey
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544
View more
  20 in total

1.  FLT3-ITD gets by with a little help from PRMT1.

Authors:  Kira Gritsman
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

Review 2.  Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse.

Authors:  Yuting Tan; Han Liu; Saijuan Chen
Journal:  Front Med       Date:  2015-12       Impact factor: 4.592

3.  Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response.

Authors:  June Li; Yasuhiro Kurasawa; Yang Wang; Karen Clise-Dwyer; Sherry A Klumpp; Hong Liang; Ramesh C Tailor; Aaron C Raymond; Zeev Estrov; Stephen J Brandt; Richard E Davis; Patrick Zweidler-McKay; Hesham M Amin; Lalitha Nagarajan
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

Review 4.  Signaling Pathways in Leukemic Stem Cells.

Authors:  Lindsay M Gurska; Kristina Ames; Kira Gritsman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 5.  Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.

Authors:  T Bochtler; S Fröhling; A Krämer
Journal:  Leukemia       Date:  2015-02-12       Impact factor: 11.528

Review 6.  Immunological effects of hypomethylating agents.

Authors:  Katherine E Lindblad; Meghali Goswami; Christopher S Hourigan; Karolyn A Oetjen
Journal:  Expert Rev Hematol       Date:  2017-07-03       Impact factor: 2.929

7.  Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells.

Authors:  Xiangguo Shi; Ayumi Kitano; Yajian Jiang; Victor Luu; Kevin A Hoegenauer; Daisuke Nakada
Journal:  Exp Hematol       Date:  2018-05-08       Impact factor: 3.084

8.  Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes.

Authors:  Kazuaki Yokoyama; Eigo Shimizu; Nozomi Yokoyama; Sousuke Nakamura; Rika Kasajima; Miho Ogawa; Tomomi Takei; Mika Ito; Asako Kobayashi; Rui Yamaguchi; Seiya Imoto; Satoru Miyano; Arinobu Tojo
Journal:  Blood Adv       Date:  2018-10-09

9.  Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.

Authors:  Peng Zhang; Fuhong He; Jie Bai; Shohei Yamamoto; Shi Chen; Lin Zhang; Mengyao Sheng; Lei Zhang; Ying Guo; Na Man; Hui Yang; Suyun Wang; Tao Cheng; Stephen D Nimer; Yuan Zhou; Mingjiang Xu; Qian-Fei Wang; Feng-Chun Yang
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

Review 10.  Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.

Authors:  David Grimwade; Adam Ivey; Brian J P Huntly
Journal:  Blood       Date:  2015-12-10       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.